NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randall MoreadithChief Scientific Officer2025-11-053,398$4.24
$14.41kSell
Randall MoreadithChief Scientific Officer2025-11-053,398$0.06
$203.88Buy
Randall MoreadithChief Scientific Officer2025-11-043,102$4.40
$13.63kSell
Randall MoreadithChief Scientific Officer2025-11-043,102$0.06
$186.12Buy
Randall MoreadithChief Scientific Officer2025-10-285,551$0.06
$333.06Buy
Randall MoreadithChief Scientific Officer2025-10-285,551$4.96
$27.54kSell
Randall MoreadithChief Scientific Officer2025-10-27949$5.19
$4.92kSell
Randall MoreadithChief Scientific Officer2025-10-27949$0.06
$56.94Buy
Randall MoreadithChief Scientific Officer2025-10-206,500$4.97
$32.29kSell
Randall MoreadithChief Scientific Officer2025-10-206,500$0.06
$390.00Buy

1 of 4

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd219.32%22,481,876$92.63MInsider
Juvenescence Us Corp160.45%16,447,500$67.76MInsider
Steven A. Ledger3.16%323,657$1.33MInsider
Vanguard Group Inc1.47%150,623$620.57kInstitution
John F. Mauldin1.22%125,000$515.00kInsider
Broadwood Capital Inc0.83%85,219$351.10kInstitution
Waverly Advisors LLC0.66%67,492$278.07kInstitution
Gregory Bailey0.66%67,243$277.04kInsider
Tacey Viegas0.57%58,610$241.47kInsider
Judith Segall0.51%52,624$216.81kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER1.03%98.97%Net BuyingNet Buying
TPST1.84%98.16%
GRCE27.60%50.93%
LVTX30.61%11.62%Net SellingNet Selling
OKUR29.82%70.18%Net SellingNet Selling

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 4.03% institutional shareholders, 387.03% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 219.32% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $92.63M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.